Eisai Co. Ltd., of Woodcliff Lake, N.J., said it entered a collaboration with nonprofit organization Liverpool School of Tropical Medicine (LSTM) and the University of Liverpool to identify new drugs against lymphatic filariasis and onchocerciasis (river blindness), both major types of the parasitic tropical disease filariasis.